JUN 12, 2019 7:58 AM PDT

Sustainable Production of Opiate Antidotes

WRITTEN BY: Nouran Amin

According to the National Center for Health Statistics, an estimated 130 Americans die every day from an opioid overdose. The skyrocketing of opiate overdoses may be largely due to the high cost of antidotes like NARCAN®--that prevent many first responders from retrieving lifesaving antidotes when needed the most.

Now, researchers at the Donald Danforth Plant Science Center were encouraged to seek sustainable methods of producing lifesaving opiate antidotes at reduced cost. The new method involves the production of compounds using a microorganism found in waste streams and associated with the processing of opium poppy.

The essence of what is known as “green chemistry” holds the potential of creating new drugs at a reduced cost with less harmful waste—and in this case the cost of antidote drug development without the need of too much chemicals.

Learn more about green chemistry:

Details of the drug development were described in the paper "Enzyme morphinan N-demethylase for more sustainable opiate processing" and published in the journal Nature Sustainability.

"Enzymes perform reactions at efficiencies that surpass synthetic chemistry, thereby reducing the cost and impact of drug production on the environment. We work now to optimize production levels of the enzyme to a scale sufficient for industrial processes. Greener manufacturing would make a difference in people's lives," said Megan Augustin, lead author and research associate in the Kutchan lab at the Danforth Center.

Essentially, naturally occurring opiates are produced in poppy species— like morphine and the baine. However, current methods of opiate conversion to pain killers result in a reaction called N-demethylation that are based on noxious reagents that produce harmful waste.

Therefore, the study identified a unique sustainable method of opiate production that is based on enzymes rather than ‘chemicals’. These enzymes can be provided by microorganisms that can be metabolized into unique compounds in their environment.

Source: Donald Danforth Plant Science Center

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 23, 2019
Drug Discovery & Development
NOV 23, 2019
Drug Seeks To Target Treatment-Resistant Epilepsy
Ever imagined a world where you cannot shower alone, drive by yourself, and even go to work in fear of having the next seizure that can incapacitate you? U...
DEC 25, 2019
Drug Discovery & Development
DEC 25, 2019
New Drug to Make Breast Cancer Treatment More Affordable
The US Food and Drug Administration has granted accelerated approval to new breast cancer drug, trastuzumab deruxtecan. The drug’s increasing recogni...
JAN 15, 2020
Drug Discovery & Development
JAN 15, 2020
FDA Approves Drugs Faster than Ever- But is That Good?
The Food and Drug Administration (FDA) is approving new drugs for patients on less and less evidence thanks to special programs that streamline their appro...
JAN 16, 2020
Health & Medicine
JAN 16, 2020
Babies in Africa Receive World's First Malaria Vaccine
Would you accept a vaccine that was only 40% effective? For those at risk of malaria, the answer is likely a resounding, "yes!" According to the...
JAN 21, 2020
Drug Discovery & Development
JAN 21, 2020
Drug Targets Gastrointestinal Cancer
The FDA has recently approved Ayvakit (avapritinib) for the treatment of unresectable and metastatic gastrointestinal stromal tumor (GIST) that occurs most...
FEB 10, 2020
Cancer
FEB 10, 2020
New hope for KRAS-mutant pancreatic cancers
A study published recently in the journal Cancer Research showcases the findings from new research on pancreatic cancer. The study was led by Frank Mc...
Loading Comments...